Poseida Therapeutics, Inc. (PSTX)
NASDAQ: PSTX · Real-Time Price · USD
9.45
+0.04 (0.43%)
At close: Dec 20, 2024, 4:00 PM
9.36
-0.09 (-0.95%)
After-hours: Dec 20, 2024, 6:29 PM EST
Poseida Therapeutics Market Cap
Poseida Therapeutics has a market cap or net worth of $921.06 million as of December 20, 2024. Its market cap has increased by 215.81% in one year.
Market Cap
921.06M
Enterprise Value
772.93M
1-Year Change
215.81%
Ranking
Category
Stock Price
$9.45
Market Cap Chart
Since July 10, 2020, Poseida Therapeutics's market cap has decreased from $948.87M to $921.06M, a decrease of -2.93%. That is a compound annual growth rate of -0.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 921.06M | 186.67% |
| Dec 29, 2023 | 321.30M | -29.47% |
| Dec 30, 2022 | 455.53M | 7.02% |
| Dec 31, 2021 | 425.67M | -37.23% |
| Dec 31, 2020 | 678.17M | -28.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Owens & Minor | 973.12M |
| HealthStream | 948.64M |
| The Pennant Group | 937.71M |
| Zymeworks | 935.36M |
| Gyre Therapeutics | 914.87M |
| Nuvation Bio | 905.36M |
| Replimune Group | 904.84M |
| Pacira BioSciences | 903.61M |